As CD8+ T cells are responsible for the main tumor-killing effect in T cell therapy, we further concentrated on the functional annotation of CD8+ T cell subpopulations according to their distinct signature gene expression (Fig. 7b, Supplementary Fig. 8a, b and Supplementary Table S1). This evidence concerns the gene CD8A and neoplasm.